HR estimates from multivariate∗ Cox regression of OS and disease-free survival on AO exposure history
| Histology . | AO-OS . | AO disease–specific survival . | ||||||
|---|---|---|---|---|---|---|---|---|
| HR . | 95% confidence limits . | P value . | HR . | 95% confidence limits . | P value . | |||
| BL | 0.855 | 0.320 | 2.285 | .6808 | 0.557 | 0.070 | 4.413 | .5792 |
| CLL | 0.813 | 0.658 | 1.004 | .0544 | 1.334 | 0.936 | 1.902 | .1110 |
| CTCL | 0.718 | 0.482 | 1.071 | .1045 | 0.758 | 0.328 | 1.755 | .5177 |
| DLBCL | 0.748 | 0.653 | 0.857 | <.0001 | 0.926 | 0.772 | 1.110 | .4060 |
| FL | 0.876 | 0.730 | 1.050 | .1313 | 0.796 | 0.591 | 1.071 | .1321 |
| HL | 0.768 | 0.571 | 1.034 | .0353 | 0.739 | 0.468 | 1.166 | .1933 |
| LPL | 0.918 | 0.252 | 3.349 | .8974 | † | |||
| MCL | 0.710 | 0.532 | 0.946 | .0195 | 0.728 | 0.503 | 1.054 | .0925 |
| MTNKL | 0.696 | 0.436 | 1.113 | .1303 | 0.966 | 0.523 | 1.783 | .9121 |
| MZL | 0.624 | 0.459 | 0.850 | .0028 | † | |||
| NOS | 0.737 | 0.586 | 0.928 | .0093 | 0.765 | 0.554 | 1.058 | .1059 |
| Histology . | AO-OS . | AO disease–specific survival . | ||||||
|---|---|---|---|---|---|---|---|---|
| HR . | 95% confidence limits . | P value . | HR . | 95% confidence limits . | P value . | |||
| BL | 0.855 | 0.320 | 2.285 | .6808 | 0.557 | 0.070 | 4.413 | .5792 |
| CLL | 0.813 | 0.658 | 1.004 | .0544 | 1.334 | 0.936 | 1.902 | .1110 |
| CTCL | 0.718 | 0.482 | 1.071 | .1045 | 0.758 | 0.328 | 1.755 | .5177 |
| DLBCL | 0.748 | 0.653 | 0.857 | <.0001 | 0.926 | 0.772 | 1.110 | .4060 |
| FL | 0.876 | 0.730 | 1.050 | .1313 | 0.796 | 0.591 | 1.071 | .1321 |
| HL | 0.768 | 0.571 | 1.034 | .0353 | 0.739 | 0.468 | 1.166 | .1933 |
| LPL | 0.918 | 0.252 | 3.349 | .8974 | † | |||
| MCL | 0.710 | 0.532 | 0.946 | .0195 | 0.728 | 0.503 | 1.054 | .0925 |
| MTNKL | 0.696 | 0.436 | 1.113 | .1303 | 0.966 | 0.523 | 1.783 | .9121 |
| MZL | 0.624 | 0.459 | 0.850 | .0028 | † | |||
| NOS | 0.737 | 0.586 | 0.928 | .0093 | 0.765 | 0.554 | 1.058 | .1059 |
BL, Burkitt lymphoma; CTCL, cutaneous T-cell lymphoma; DSS, disease-specific survival; FL, follicular lymphoma; HL, Hodgkin lymphoma; HR, hazard ratio; LPL, lymphoplasmacytic lymphoma; MCL, mantle cell lymphoma; MTNKL, mature T-cell and natural killer cell lymphoma.
Adjusted for race, tobacco history, military branch, rank, combat history, year of birth, age at diagnosis, year of diagnosis, and stage at diagnosis.
Number of events not adequate for multivariate analysis.